prednisone has been researched along with Leishmaniasis, Cutaneous in 5 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
Excerpt | Relevance | Reference |
---|---|---|
"We report four patients with rheumatoid arthritis, treated with methotrexate and prednisone who developed cutaneous leishmaniasis." | 3.75 | [Cutaneous leishmaniasis in rheumatoid arthritis]. ( Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M, 2009) |
" In our patient, both polymyositis and steroid therapy were predisposing factors of cutaneous leishmaniasis onset; prednisone therapy has been postulated to be associated with immune dysfunction leading to: reduced blood T cells' levels (CD4 et CD8) as well as decreased cytokine synthesis (e." | 3.73 | [Cutaneous leishmaniasis in polymyositis]. ( Bernet, J; Courville, P; Favennec, L; Fevre, C; Levesque, H; Marie, I, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernandez Bel, L | 1 |
Hernández Garfella, ML | 1 |
Chiarri Toumit, C | 1 |
Valenzuela Oñate, C | 1 |
Garrido Colmenero, C | 1 |
Arias Santiago, S | 1 |
Blasco Morente, G | 1 |
Martín Castro, A | 1 |
Hachicha, I | 1 |
Sellami, M | 1 |
Fourati, H | 1 |
Akrout, R | 1 |
Hdiji, N | 1 |
Baklouti, S | 1 |
Bouomrani, S | 1 |
Farah, A | 1 |
Ayadi, N | 1 |
Béji, M | 1 |
Marie, I | 1 |
Fevre, C | 1 |
Favennec, L | 1 |
Courville, P | 1 |
Bernet, J | 1 |
Levesque, H | 1 |
5 other studies available for prednisone and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Anti-tumour necrosis factor-induced cutaneous leishmaniasis in patient with psoriatic arthritis and uveitis.
Topics: Adalimumab; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Disease Susceptibility; Drug Therapy, | 2018 |
[Chronic ulcer in nasal vestibule].
Topics: Chronic Disease; Diagnosis, Differential; Female; Granuloma, Lethal Midline; Humans; Immunocompromis | 2014 |
[Cutaneous leishmaniasis in rheumatoid arthritis].
Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromis | 2009 |
[Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].
Topics: Adolescent; Anti-Inflammatory Agents; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis | 2011 |
[Cutaneous leishmaniasis in polymyositis].
Topics: Adult; Animals; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Immunoglobulins, Intraven | 2006 |